Back to Search Results
Kari Kendra
Schedule an appointment (614) 293-4320
Insurances We Accept
I am a medical oncologist focusing on skin cancers and an associate professor of internal medicine. I also serve as chair of the Melanoma Disease Specific Committee. I’m the attending physician for in-patient and outpatient solid tumor services at the OSUCCC – James. I was rated in the top 10 percent of physicians in the nation in 2016 for patient satisfaction.

My clinical and research focus is treating patients with melanoma, the deadliest of all skin cancers, and other related skin cancers. Everyone’s cancer is unique so our approach is to look at the individual patient and the mutations within their tumors. We then decide which is the best therapy for the optimal long-term benefit.

We’ve made tremendous strides in treating the disease. Tumors can become resistant to the drugs we have so there are studies on how to prevent the development of this resistance. And we have studies on how to overcome the resistance in a patient who has already had taken the drug successfully but now has become resistant. Patients with Stage 4-melanoma typically had a six- to nine-month survival rate after diagnosis. Now with new drugs and trials, we’ve extended that.

I feel privileged to be part of entire The Ohio State University medical community, and I’m especially proud to contribute to the overall mission of The James: to provide cutting-edge research and superior personalized care to each and every one of our patients.

Medical Degree

  • M.D.
    Rush Presbyterian Hospital
    6/30/1990

Residency

  • Internal Medicine
    University of Wisconsin School of Medicine
    7/1/1991 - 6/30/1993

Specialties and conditions I treat

  • Medical Oncology
  • Melanoma
  • Skin Cancers
  • Eye Cancers
  • Uveal Cancers
  • Carcinoma, Merkel Cell
  • Melanoma, Amelanotic
  • Melanoma, Experimental
  • Hutchinson's Melanotic Freckle
  • Carcinoma, Basal Cell
  • Carcinoma, Basosquamous
  • Carcinoma, Squamous Cell
  • Basal Cell Nevus Syndrome
  • Bowen's Disease
  • Basal Cell Cancer
  • Squamous Cell Cancer
  • Neuroectodermal Tumor, Melanotic
  • Nevi and Melanomas

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

More about my work

My background

Fellowships

  • Medical Oncology
    University of Wisconsin School of Medicine
    7/1/1994 - 6/30/1996
  • Medical Oncology
    University of Rochester School of Medicine
    7/1/1998 - 6/30/2001

Board Certifications

American Board of Internal Medicine
8/20/1997

American Board of Internal Medicine (Subspecialty: Medicine Oncology)
11/3/1999

My Department

Internal Medicine

My Division

Medical Oncology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies, etc. because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/25/2016, Dr. Kendra has reported no financial relationships with medical device, research and/or drug companies, etc. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.